Lev El Diagnostic

Lev El Diagnostic Overview

Lev-El Diagnostics is a medical technology company specializing in the noninvasive detection of cardiovascular diseases. The companys initial product, HeartTrends, is a cardiac stress test alternative. HeartTrends is designed to assist in the detection of myocardial ischemia related to coronary artery disease (CAD) at an early stage. HeartTrends can be used as a general tool for screening both sick and healthy individuals. The HeartTrends software analyzes R-R interval measurements captured from a certified, off-the-shelf Holter monitor during a short at-rest heart test. Immediately following the procedure, HeartTrends can generate a Dy/Dx indicator value to assist qualified personnel in detecting myocardial ischemia related to CAD.

Latest News

Dec 2, 2019 · medcitynews.com

growth-positive

Startup says algorithm identifies new risk factor for heart disease but a doctor is skeptical

Lev El Diagnostics of Heart Diseases, an Israeli biotech company, has developed an algorithm called HeartTrends that analyzes heart-rate variation as a new risk factor for heart disease. A clinical study led by Dr. Ilan Goldenberg has endorsed the predictive power of the algorithm. HeartTrends listens to heartbeats through a wearable monitor connected to an app and sends data to Lev El for analysis. The algorithm is FDA-cleared and currently used by life insurers in other countries. Lev El aims to gain a foothold in the US through life insurers and sees a bigger role in healthcare. The companys website promotes the test as ideal for healthy adults with risk factors or those unable to undergo traditional stress tests. The study showed that the algorithm was more likely to predict myocardial ischemia than conventional stress tests.

Customers

Nov 11, 2019 · www.prnewswire.com

growth-positive

Multi-Center Clinical Study Demonstrates HeartTrends® Improves Early Detection for Heart Disease in Healthy Individuals

Lev El Diagnostics of Heart Diseases Ltd. announced the results of a clinical study on the correlation between heart rate variability (HRV) and myocardial ischemia. The study demonstrated that HeartTrends HRV analysis improves early detection of myocardial ischemia compared to traditional cardiovascular risk factors. The technology can be implemented on wearable smart-devices, making it time-efficient and cost-effective. The study provides a new and independent cardiac risk factor for physicians. Lev El Diagnostics specializes in non-invasive cardiovascular disease detection based on patented, machine learning AI algorithms.

Customers

Apr 14, 2015 · www.prweb.com

growth-positive

Breakthrough Test for Early Detection of Coronary Artery Disease Superior to Exercise Stress Testing

A clinical study has found that HeartTrends, developed by Lev El Diagnostics of Heart Disease Ltd., can detect ischemic heart disease more accurately than traditional exercise stress tests. The test analyzes just 1 hour of heart data without the need for any special maneuvers or heart stress, making it advantageous for the elderly and handicapped. The study showed that HeartTrends diagnosed three times more patients with heart disease than exercise stress testing. Additionally, the study found that the expensive and potentially radioactive Myocardial Perfusion Imaging test was overused and not required in over 93% of patients. The use of HeartTrends could reduce costs and the use of radionuclide dyes. The CEO of Lev El Diagnostics of Heart Disease Ltd. believes that HeartTrends could become part of standard annual testing checkups and reduce healthcare costs.

Customers

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

Zarhin Street 10, Ra'anana, Israel

Photos & Videos

2 item(s)

Lev El Diagnostic Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info